Status:
RECRUITING
Piloting a Patient Navigator Program for Weight Loss
Lead Sponsor:
Drexel University
Collaborating Sponsors:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions:
Obesity
Overweight
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
Evidence-based interventions for overweight and obesity are underutilized. The utilization and efficacy of these interventions may improve with the implementation of a patient navigator program, as ha...
Detailed Description
Most adults who attempt weight loss do not use evidence-based interventions; instead, they engage in self-directed dieting, which is typically short-lived and has poor efficacy. These individuals ofte...
Eligibility Criteria
Inclusion
- Inclusion criteria include:
- BMI \> 27 kg/m2
- weight \< 396 pounds due to limits of the wireless scale
- age 18 to 75
- ability to read and speak English sufficiently to engage with a counselor and complete study measures
- willing to be randomized to either study condition
- willing to engage with a counselor for assistance in identifying and initiating a weight loss intervention
- successfully complete enrollment and assessments tasks, including connecting a wireless scale for baseline measurement of weight
- reliable access to a device capable of using email and Drexel approved videoconferencing software
- residing in the greater Philadelphia metropolitan area, which includes Southeastern PA, Southern NJ, Northeast MD, and Northern DE
- agree that they will not join another intervention study in the WELL Center in the next 12 months
- Exclusion criteria include:
- a medical or psychiatric condition that may a) limit appropriateness of weight loss intervention or b) be likely to cause a change in weight in the next 12 months (e.g., anorexia nervosa, bulimia nervosa, end-stage kidney disease, some types of cancer)
- currently taking weight loss medication or engaging in any other form of weight management intervention
- history of bariatric surgery
- a calculated weight suppression value of 10% or higher
- currently pregnant or planning to become pregnant in the next 12 months
- adults unable to consent, children, pregnant women, and prisoners
Exclusion
Key Trial Info
Start Date :
September 15 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 15 2027
Estimated Enrollment :
68 Patients enrolled
Trial Details
Trial ID
NCT06972381
Start Date
September 15 2025
End Date
February 15 2027
Last Update
November 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Drexel university
Philadelphia, Pennsylvania, United States, 19104